Skip to main content
Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.880
-0.010 (-0.53%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Inhibikase Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
35
Market Cap
320.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023260.50K137.06K111.03%
Dec 31, 2022123.44K-2.98M-96.02%
Dec 31, 20213.10M2.40M343.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

IKT News

More News